Paper19085952
CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes.
Ye L and 8 others. Hepatology, 2009. Cited by 45 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Papers, record 19085952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19085952
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD56 Antigen | Major topic |
| Hepacivirus | Major topic |
| Hepatocytes | Major topic |
| T-Lymphocytes | Major topic |
| Virus Replication | Major topic |
| Cell Communication | |
| Cell Line | |
| Cells, Cultured | |
| Coculture Techniques | |
| Female | |
| Hepatitis C | |
| Humans | |
| Interferon-alpha | |
| Interferon-beta | |
| Interferon-gamma | |
| Janus Kinases | |
| Male | |
| RNA, Viral | |
| STAT Transcription Factors | |
| Signal Transduction |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 DA025477 | NIDA NIH HHS | United States | R21DA025477 | PubMed and NIH | NIH RePORTER |
| DA 12815 | NIDA NIH HHS | United States | R01DA012815 | PubMed and NIH | NIH RePORTER |
| R01 DA022177 | NIDA NIH HHS | United States | R01DA022177 | PubMed and NIH | NIH RePORTER |
| R01 DA012815 | NIDA NIH HHS | United States | R01DA012815 | PubMed and NIH | NIH RePORTER |
| DA 22177 | NIDA NIH HHS | United States | R01DA022177 | PubMed and NIH | NIH RePORTER |
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,882,050 | CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. | Clin Exp Immunol | 2002 | https://conductscience.org/library/papers/11882050 | PubMed |
| 2 | 15,922,665 | Viruses know it all: new insights into IFN networks. | Trends Immunol | 2005 | https://conductscience.org/library/papers/15922665 | PubMed |
| 3 | 11,747,627 | Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence. | J Interferon Cytokine Res | 2001 | https://conductscience.org/library/papers/11747627 | PubMed |
| 4 | 17,502,370 | The interferon regulatory factor family in host defense: mechanism of action. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17502370 | PubMed |
| 5 | 12,368,359 | Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. | J Virol | 2002 | https://conductscience.org/library/papers/12368359 | PubMed |
| 6 | 10,807,503 | Innate and adaptive lymphoid cells in the human liver. | Immunol Rev | 2000 | https://conductscience.org/library/papers/10807503 | PubMed |
| 7 | 7,519,209 | A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. | J Immunol | 1994 | https://conductscience.org/library/papers/7519209 | PubMed |
| 8 | 10,438,977 | The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. | J Immunol | 1999 | https://conductscience.org/library/papers/10438977 | PubMed |
| 9 | 12,442,327 | NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production. | Eur J Immunol | 2002 | https://conductscience.org/library/papers/12442327 | PubMed |
| 10 | 16,175,599 | Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines. | Hepatology | 2005 | https://conductscience.org/library/papers/16175599 | PubMed |
| 11 | 11,507,197 | Effect of alpha interferon on the hepatitis C virus replicon. | J Virol | 2001 | https://conductscience.org/library/papers/11507197 | PubMed |
| 12 | 9,806,058 | The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. | J Infect Dis | 1998 | https://conductscience.org/library/papers/9806058 | PubMed |
| 13 | 15,905,121 | Changes in natural killer T cells subsets during therapy in type C hepatitis and hepatocellular carcinoma. | Hepatol Res | 2005 | https://conductscience.org/library/papers/15905121 | PubMed |
| 14 | 16,107,965 | CD8+ T cell depletion amplifies hepatitis C virus replication in peripheral blood mononuclear cells. | J Infect Dis | 2005 | https://conductscience.org/library/papers/16107965 | PubMed |
| 15 | 3,088,199 | A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. | J Exp Med | 1986 | https://conductscience.org/library/papers/3088199 | PubMed |
| 16 | 17,553,896 | Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection. | J Virol | 2007 | https://conductscience.org/library/papers/17553896 | PubMed |
| 17 | 12,076,868 | Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. | J Hepatol | 2002 | https://conductscience.org/library/papers/12076868 | PubMed |
| 18 | 17,145,366 | Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. | Hum Immunol | 2006 | https://conductscience.org/library/papers/17145366 | PubMed |
| 19 | 16,141,076 | Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. | Science | 2005 | https://conductscience.org/library/papers/16141076 | PubMed |
| 20 | 17,943,132 | Interferon modulation of cellular microRNAs as an antiviral mechanism. | Nature | 2007 | https://conductscience.org/library/papers/17943132 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,911,797 | Human CD8+ T-Cell Populations That Express Natural Killer Receptors. | Immune Netw | 2023 | https://conductscience.org/library/papers/36911797 | PubMed |
| 36,159,876 | Hepatic iNKT cells produce type 2 cytokines and restrain antiviral T cells during acute hepacivirus infection. | Front Immunol | 2022 | https://conductscience.org/library/papers/36159876 | PubMed |
| 33,400,242 | Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. | Drugs | 2021 | https://conductscience.org/library/papers/33400242 | PubMed |
| 32,966,988 | Modulation of Immune Cell Subsets by Hepatitis C Virus and Antiviral Therapy in Early Virological Response HCV Genotype 4-Infected Patients with Compensated Liver Disease. | Med Princ Pract | 2021 | https://conductscience.org/library/papers/32966988 | PubMed |
| 30,425,710 | The Role of CD1d and MR1 Restricted T Cells in the Liver. | Front Immunol | 2018 | https://conductscience.org/library/papers/30425710 | PubMed |
| 28,529,568 | A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma. | Oncol Lett | 2017 | https://conductscience.org/library/papers/28529568 | PubMed |
| 28,380,039 | Alterations of the NK cell pool in HIV/HCV co-infection. | PLoS One | 2017 | https://conductscience.org/library/papers/28380039 | PubMed |
| 28,321,215 | IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages. | Front Immunol | 2017 | https://conductscience.org/library/papers/28321215 | PubMed |
| 28,276,509 | Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells. | Sci Rep | 2017 | https://conductscience.org/library/papers/28276509 | PubMed |
| 27,814,766 | Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection. | Retrovirology | 2016 | https://conductscience.org/library/papers/27814766 | PubMed |
| 27,752,051 | Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy. | Sci Rep | 2016 | https://conductscience.org/library/papers/27752051 | PubMed |
| 27,605,546 | Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes. | FASEB J | 2016 | https://conductscience.org/library/papers/27605546 | PubMed |
| 27,502,318 | Donor-unrestricted T cells in the human CD1 system. | Immunogenetics | 2016 | https://conductscience.org/library/papers/27502318 | PubMed |
| 27,239,111 | Immunological changes in different patient populations with chronic hepatitis C virus infection. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/27239111 | PubMed |
| 27,174,425 | CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients. | Sci Rep | 2016 | https://conductscience.org/library/papers/27174425 | PubMed |
| 26,972,772 | NKT cell subsets as key participants in liver physiology and pathology. | Cell Mol Immunol | 2016 | https://conductscience.org/library/papers/26972772 | PubMed |
| 25,965,701 | Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C. | PLoS One | 2015 | https://conductscience.org/library/papers/25965701 | PubMed |
| 25,875,501 | The roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication. | PLoS One | 2015 | https://conductscience.org/library/papers/25875501 | PubMed |
| 25,738,504 | Circulating microRNA-196a as a candidate diagnostic biomarker for chronic hepatitis C. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/25738504 | PubMed |
| 23,647,955 | Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes. | J Viral Hepat | 2013 | https://conductscience.org/library/papers/23647955 | PubMed |
Genes53
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19085952
GET https://conductscience.org/api/papers/v1/19085952/references?page=2